Summary
Tiapride, a substituted benzamide derivative, possesses good clinical antidyskinetic properties due to its DA2-blocking activities. It has been shown to be clinically effective in the treatment of tic disease in children. In order to study tiapride's antidyskinetic properties in the treatment of the tic syndrome in children, we conducted a simple, placebo-controlled study on 10 children followed by a double-blind crossover study on 17 children. Tiapride was shown to have a positive therapeutic effect on tics in children; whereas it has no adverse effects on neuropsychologically measurable cognitive performances in children. Neurophysiological parameters such as the EEG frequency analysis and sensory evoked potentials were not affected by tiapride, nor was the neurosecretory, hypothalamic-hypophyseal regulation of the sex hormones, thyroid stimulating hormone, growth hormone, or thyroid hormone impaired. The hyperprolactinemia caused by tiapride's dopaminergic properties was moderate and restricted to the duration of therapy.
Similar content being viewed by others
References
Brosteanu EF, Floru L (1980) Untersuchung der visuell evozierten Potentiale bei schizophrenen Patienten unter einer Behandlung mit Sulpirid. Arzneimittelforsch 30:1305–1309
Burt DR, Creese J, Snyder SH (1977) Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196:326–328
Chouza C, Romero S, Lorenzo J, Camano JL, Fontana AP, Alterwain P, Cibils D, Gaudiano J, Feres S, Solana J (1982) Traitement des dyskinésies par le tiapride. Sem Hôp (Paris) 58:725–733
Costall B, Naylor RJ (1979) Behavioural aspects of dopamine agonists and antagonists. In: Horn AS, Korf J, Westerrink BH (Hrsg) The neurobiology of dopamine. Academic Press, London New York San Francisco
Costall B, Naylor RJ (1983) The substituted benzamides: Selective dopamine receptor blockade. In: Ackenheil M, Matussek N (Hrsg) Special aspects of psychopharmacology. Expansion Scientifique Francaise, Paris
Eggers Ch (1982) Pathophysiologie von Tic-Erkrankungen. Psychophysiologische und neurophysiologische Untersuchungsmethoden — Erfahrungen mit Tiapridex in der Therapie des Tic-Syndroms. In: Aschoff JC (Hrsg) Die Therapie extrapyramidal-motorischer Erkrankungen. Schattauer, Stuttgart
Eggers Ch, Olbricht T, Rothenberger A (1983) Neurobiological findings in children with tics and Gilles de la Tourette syndrome. In: Ackenheil M, Matussek N (eds) Special aspects of psychopharmacology. Expansion Scientifique Francaise, Paris
Fuxe K, Ögren SO, Hall H, Agnati LF, Andersson K, Köhler C, Schwarcz R (1980) Effects of chronic treatment with Lsulpiride and haloperidol on central monoaminergic mechanisms. In: Cattabani F (Hrsg) Long-term effects of neuroleptics. Raven Press, New York
Fuxe K, Agnati LF, Andersson K, Calza L, Benfenati F, Zini I, Battistini N, Köhler C, Ögren SO, Hökfelt T (1983) Analysis of transmitter-identified neurons by morphometry and quantitative microfluorimetry. Evaluation of the actions of psychoactive drugs, especially sulpiride. In: Ackenheil M, Matussek N (Hrsg) Special aspects of psychopharmacology. Expansion Scientifique Francaise, Paris
Gennari C, Nami R, Pizzuti M, D'Ascenzo G, Bianchini C (1981) Effets du tiapride en perfusion sur le taux plasmatique de bêta-endorphine, prolactine et dopamine chez des patients souffrant d'algies cancéreuses. Sem Hôp (Paris) 57:795–800
Harnack GA von (1958) Nervöse Verhaltensstörungen beim Schulkind. Thieme, Stuttgart
Kanner L (1957) Child psychiatry. Thomas, Springfield/III
L'Hermite M, McLeod RM, Robyn C (1978) Effects of two substituted benzamides, tiapride and sultopride, on gonadotrophins and prolactin. Acta Endocrinol 89:29–36
L'Hermite M, Michaux-Duchňe A, Robyn C (1979) Tiapride-induced chronic hyperprolactinaemia: interference with the human menstrual cycle. Acta Endocrinol 92:214–227
Memo M, Battaini F, Spano PF, Trabucchi M (1981) Sulpiride and the role of dopaminergic receptor blockade in the antipsychotic activity of neuroleptics. Acta Psychiatr Scand 63:314–324
Portioli I, Modena G, Fantesini C, Bellefelli A, Dotti C (1976) Interelations TRH-sulpiride sur la sécrétion de prolactine. Nouv Presse Méd 5:931
Pringle ML, Butler NR, Davie R (1967) 11000 seven year olds. National Bureau for corporation in child. Case, London
Regeur L, Pakkenberg B, Fog R, Pakkenberg H (1986) Clinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette's syndrome. J Neurol Neurosurg Psychiatr 49:791–795
Remschmidt H, Remschmidt U (1974) Symptomatologie, Verlauf und Prognose von Tic-Erkrankungen im Kindes- und Jugendalter. Klin Pädiatr 186:185–199
Rothenberger A (1984) Therapie der Tic-Störungen. Z Kinder-Jugendpsychiatr 12:284–301
Rutter M, Shaffer D, Sturge C (1976) A guide to a multi-axial classification scheme for psychiatric disorders in childhood and adolescence. Institute of psychiatry, London
Saletu B (1977) Cerebral evoked potentials in psychopharmacology. In: Desmedt JE (Hrsg) Auditory evoked potentials in man. Psychopharmacology correlates of EP's. Karger, Basel (Prog Clin Neurophysiol, vol 2) pp 175–207
Shagass C (1981) Psychotropic drugs and evoked potentials, paper presented at the Xth International Congress of Electroencephalography and Clinical Neurophysiology, Kyoto, Japan
Shapiro AK, Shapiro E (1984) Controlled Study of Pimozide vs. Placebo in Tourette's Syndrome. J Am Acad Child Psychiatr 23:161–173
Torup E (1962) A follow-up study of children with tics. Acta Paediatr 51:261–268
Zausmer RCM (1954) Treatment of tics in childhood. Arch Dis Child 29:537–542
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eggers, C., Rothenberger, A. & Berghaus, U. Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride. Eur Arch Psychiatr Neurol Sci 237, 223–229 (1988). https://doi.org/10.1007/BF00449911
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00449911